Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Hospitals Launch Generic Drug Company Civica Rx to Drive Down Drug Prices

In January 2018, it was announced that five healthcare systems were launching a not-for-profit generic drug company. That company now has a name, Civica Rx.

Read More »

FCB Health Network Launches Its First-Ever Latin American Offering in Brazil

FCB Health Network, the 2018 Cannes Lions “Healthcare Network of the Year,” announced the launch of FCB Health Brasil.

Read More »

First Year After Launch Special Feature 2018: Don’t look back, someone might be gaining

The top performers of the launch class of 2016 have very little in common – aside from the fact that none of them came from a “classic” big pharma house.

Read More »

Rockpointe and AudioEducate launch first-ever accredited CME program on Amazon’s Echo

The CME provider Rockpointe launched the first CME-certified course ever offered on Amazon Echo through the AudioEducate platform with joint providers Potomac Center for Medical Education (PCME) and the Academy of Physicians in Clinical Research (APCR).

Read More »

CrowdPharm Heralds A New Era For Healthcare Marketing

Agency veterans Mike Myers and Steve Bernstein launched a new strategic and creative agency model called CrowdPharm.

Read More »

Novartis’ digital drive continues with eye-disease app

Novartis’ foray into digital technology intensified as the Swiss drugmaker launched a mobile-phone based app to help collect data from people participating in eye disease studies.

Read More »

Foghorn Therapeutics Launches with $50 Million

Foghorn Therapeutics, based in Cambridge, Massachusetts, officially launched with a $50 million investment from Flagship Pioneering and associated investors.

Read More »

Superstar Investors Jump in on Celgene Spinout Celularity’s $250 Million Funding Round

With a high-profile group of investors and backers, Celgene Corp. spinout Celularity launched with $250 million.

Read More »

Partner Therapeutics Nabs $60 Million, Acquires Leukine From Sanofi

One week after launching, Partner Therapeutics acquired the global rights to Leukine (sargramaostin) from Paris-based Sanofi.

Read More »

Reaction Biology launches ion channel division

Reaction Biology Corporation, a leading contract research organization providing early-stage drug discovery services, announced that it has launched a new division to provide ion-channel discovery services.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

October 2019 Focus: Top 50 Company Profiles & Financials, Outcomes Creativity Index, and more!


Ad Right Bottom